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Abstract
Purpose—In California, colorectal cancer (CRC) is the second most common cancer in Latinos. 
Using data from the California Cancer Registry we investigated demographic and clinical 
characteristics of 36,133 Latinos with CRC living in California during 1995–2011 taking into 
account subpopulations defined by country of origin.
Methods—Cases were defined as Latino according to the North American Association of Central 
Cancer Registries Hispanic Identification Algorithm, which was also used to group cases by 
country of origin: Mexico (9,678, 27%), Central or South America (2,636, 7%), Cuban (558, 2%), 
Puerto Rico (295, 1%), and other or unknown origin (22,966, 64%; Other/NOS). 174,710 non-
Hispanic white (NHW) CRC cases were included for comparison purposes. Annual age-adjusted 
incidence rates (AAIR) and proportional incidence ratios (PIRs) were calculated.
Results—Differences were observed for age at diagnosis, sex distribution, socioeconomic status 
(SES), nativity (US- versus foreign-born), stage, and tumor localization across Latino 
subpopulations and compared to NHW. Mexican-Latinos had the lowest AAIR and Cuban Latinos 
had the highest. PIRs adjusted for age, SES, and nativity showed an excess of CRC males and 
female cases from Cuba, female cases from Puerto Rico and reduced number of female cases from 
Mexico.
Conclusions—Differences in cancer incidence patterns and tumor characteristics were observed 
among Latino subpopulations in California. These disparities may reflect differences in cancer 
determinants among Latinos; therefore, given that country of origin information is unavailable for 
a large proportion of these patients, greater efforts to collect these data are warranted.
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INTRODUCTION
Latinos are the largest and the fastest growing minority ethnic group in the US; with a 
population of 54 million they currently account for 17.1% of the US population (US Census 
Bureau, 2013). This proportion is predicted to increase to 25% by the year 2050. California 
is home to 14.7 million Latinos, who represent 38.4% of the population and 27% of the total 
US Latino population (US Census Bureau 2013). Among Latinos living in California 83% 
are of Mexican origin, 9.2% are from Central America, 2.3% are from South America, 1.5% 
are from Puerto Rico, 0.6% from Cuba, and 2.9% are of “other” Hispanic origin (e.g., Spain 
or Latinos for whom there is no information on country of origin)(US Census Bureau, 2013 
American Community Survey).
Incidence rates of the leading cancers in Latinos tend to be lower than those in non-Hispanic 
whites (NHW). However, unlike NHWs, cancer is the leading cause of death among Latinos 
[1]. Even though colorectal cancer (CRC) is the second most common cancer in Latino men 
and women, with an estimated 10,700 US Latinos diagnosed in 2012, the incidence rates are 
12% and 16% lower than those for NHW men and women in the US population, 
respectively [1]. CRC is the second and third most common cause of cancer death among 
Hispanic men and women, respectively [1]. In spite of the overall lower incidence rates 
when compared to NHW, Latinos are reported to be diagnosed with CRC at an earlier age, 
with more advanced disease and worse survival than NHW [2, 3]. Localized-stage disease, 
which is associated with improved CRC outcome, was reported to be less common among 
Latinos compared to NHW [4–6].
CRC incidence rates in US Latinos are generally higher than those reported for most Latin 
American countries [7], suggesting that changes in lifestyle, erosion of protective factors [8], 
and/or environmental risk factors present in the US contribute to increasing incidence CRC 
rates in Latino immigrants and their descendants. In understanding this, it is important to 
consider that Latinos are a highly heterogeneous group in terms of culture and racial 
composition, as this ethnic group is the result of generations of admixture of European 
immigrants, Amerindian ancestors, and Africans, with varying degrees across Latin America 
[9, 10]. The complexity of this heterogeneity is increased among US Latinos given the 
diverse origins of Latino immigrants and varying degrees of inter-mixing and acculturation 
patterns to US culture. Consistent with this heterogeneity, previous studies that aimed to 
capture the heterogeneity within Latinos in the US have reported cancer incidence patterns 
that are not uniform across US Latino subpopulations defined by country of origin using 
different approaches [6, 11, 12]. These differences in cancer risk within subgroups of 
Latinos may point to specific cancer risk factors among Latino subpopulations, and may 
help guide future cancer control strategies to reduce the impact of cancer in this growing 
minority population.
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In this study we report the frequency of key demographic and clinical characteristics of 
Latinos with CRC living in California between 1995 and 2011, taking into account Latino 




We used the cancer incidence data collected by the California Cancer Registry (CCR), from 
the October 2013 research file. Primary CRC cases diagnosed during 1995–2011 among 
Californian residents were identified by the Surveillance, Epidemiology, and End-Results 
Program (SEER) site codes (21041–21052), based on the site and histology codes as defined 
in the International Classification of Diseases for Oncology, Third Edition (ICD-O-3) [13]. 
Latino status and Latino subpopulations were identified by the NAACCR Hispanic 
Identification Algorithm (NHIA)[14]. This algorithm uses several NAACCR variables to 
classify individuals as Hispanic or non-Hispanic using information from Spanish/Hispanic 
Origin, last name, maiden name, birthplace, and race. It also allows to subgroup Hispanics 
into subpopulations defined by country of origin (birthplace). We assigned all Latino CRC 
cases to one of the following groups: Mexican, Puerto Rican, Cuban, South or Central 
American (any country from South or Central America and Caribbean except Cuba and 
Puerto Rico). Individuals of other specified countries of origin (e.g. Dominican Republic, 
Spain) as well as those individuals “not otherwise specified” due to missing birthplace 
information (NOS) were assigned to the category ‘Other/NOS’. CRC cases of NHW were 
also included in the study for comparison.
The cases were further grouped by gender (males and females), age at diagnosis (five-year 
age groups, further grouped into <50, 50–65, and >65), socioeconomic status (SES) (low, 
middle, and high), nativity (US-born and foreign-born), vital status (alive and deceased). 
The SES was grouped based on the CCR’s previously published area-based methodologies 
[15, 16] using census tract level SES information from Census 2000 and American 
Community Survey (ACS) 2007–2011 aggregated data. SES based on Census 2000 results 
was applied to cases diagnosed during 1995–2005, while the SES developed using the ACS 
data was applied to cases diagnosed during 2006–2011. Nativity (US versus foreign-born 
Latinos) was defined on reported country of birth. For 36% of Latino cases with unknown 
birthplace, nativity was estimated by using the individual’s social security number (SSN), 
using an algorithm previously described [17]. Briefly, if the SSN was issued before age 25 
years individuals were considered US born whereas those with SSN issued after age 25 
years were considered foreign born.
The CRC cases were also characterized by tumor location and behavior (in situ and 
invasive) as defined in ICD-O-3, tumor size, and stage at diagnosis (stage I-IV). Tumor size 
records the largest dimension or diameter of the primary tumor in millimeters. Tumor stage 
at diagnosis was defined by the SEER-modified AJCC staging system.
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We estimated the age-gender-specific population at risk for the entire study period by using 
the 2000 census counts for the Latino population in California stratified by the 
corresponding subcategories as in the cases and multiplied by 11 for the 1995–2005 period, 
and counts from 2010 census multiplied by 6 for 2006–2011.
Statistical Analyses
Comparison of frequencies for these different variables across Latino subpopulations and 
with NHW were done using chi-square tests or Fisher exact tests, as appropriate. We 
calculated the age-adjusted (2000 or 2010 U.S. standard population) incidence rate (AAIR) 
by gender and racial/ethnic groups, per 100,000 population. We estimated proportional 
incidence ratios (PIRs) adjusting for age, gender, SES, and nativity for Latino 
subpopulations. The adjusted PIRs were estimated by first calculating the age-gender-SES-
nativity-specific proportions of CRC cases among all cancer cases in the total Latino 
population during the study period. This proportion multiplied by the corresponding 
observed age-gender-SES-nativity-specific number of all cancer cases for each Latino 
subpopulation resulted in the expected age-gender-SES-nativity-specific number of CRC 
cases for each Latino supopulation. The expected total number of CRC cases for both 
genders for a given subpopulation group was obtained by the sum of all age-SES-nativity-
specific expected number of CRC cases. Finally, the PIR is the ratio of the observed cases to 
those expected.
RESULTS
Between the years 1995 and 2011 there were 36,133 CRC cases (20,140 in 1995–2005 and 
15,993 in 2006–2011) diagnosed in California identified as Latinos and 174,710 NHWs 
(117,720 in 1995–2005 and 56,990 in 2006–2011). Among those identified as Latino, 9,678 
(27%) were identified to be of Mexican origin, 2,636 (7%) Central or South American, 558 
(2%) Cuban, 295 (1%) Puerto Rican, and 22,966 (64%) were Latinos of other or unknown 
country of origin (Other/NOS) (Table 1). Regarding self-identified race, out of the total of 
36,133 Latinos, 35,507 (98.3%) identified as white, 178 (0.5%) as black, 152 (0.4%) as 
other races combined, and 296 (0.8%) were of race unknown. The distribution of Latino 
subpopulations were very similar for the two periods considered: 1995–2005 and 2006–2011 
(data not shown).
Demographic characteristics of Latino CRC cases in California
Table 1 summarizes the key demographic characteristics for all Latino cases and Latino 
subpopulation for the entire period of 1995–2011. As comparison, we also show the 
distribution of these characteristics for NHW. All Latinos combined showed a statistically 
significant higher proportion of cases diagnosed before 50 years old (16% in Latinos versus 
7% in NHW, p < 0.001). We also observed statistically significant differences across 
subpopulations defined by country of origin (p < 0.001). Specifically, the proportion of 
cases diagnosed before age 50 was highest among Mexicans (20%) and Central/South 
Americans (20%), followed by Latinos NOS (15%) and Puerto Ricans (9%). Cubans 
showed proportions lower than those observed among NHW (4% versus 7%, respectively)
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(Table 1). When we considered the two time periods included in these analyses, we 
observed that in the most recent period (2006–2011) there was a slight increase in 
individuals diagnosed under 50 years of age (17% vs 16% for 1995–2005) and those 
diagnosed between 50–65 years of age (38% vs 32% for 1995–2011); these differences were 
statistically significant (p< 0.001).
Overall, the proportion of female cases among Latinos was slightly lower than that of NHW 
(46% versus 49%, respectively). Among Latino subpopulations, Latinos from Mexico had 
the lowest proportion of females (43%) and Latinos from Central/South American had the 
reverse pattern than all other subpopulations, with a lower frequency of males (44% vs. 54–
57% among all other subpopulations)(p<0.001)(Table 1). The sex distribution did not vary 
significantly between the two time periods considered (data not shown).
Statistically significant differences were also observed for the distribution of cases across 
SES status levels, with Latinos having greater proportion of low SES (levels 1 and 2) than 
NHW (56% vs. 27%, p <0.001) (Table 1). Among Latinos, a greater proportion of low SES 
(levels 1 and 2) was observed among Mexicans (66%), followed by Latinos NOS (53%), 
Central/South Americans (51%), Cubans (49%) and Puerto Ricans (46%) (p <0.001). 
Results did not differ significantly across the two periods considered (data not shown).
Nativity information was unknown for 36% of Latinos and was therefore imputed. Among 
all Latino cases combined, 53% were reported to be US born. There was a wide range of 
variation across the different subpopulations. Whereas among Latinos of Mexican origin 
16% were US born, only 1% of South/Central American Latinos were US born. Among 
Puerto Ricans 11% were US born, and 3% among Cubans. The majority of Latinos of other 
or unknown origin were US born (77%).
The proportion of deceased patients within this time period was lower in Latinos compared 
to NHW (51% vs 60%, p<0.001); however, within Latino subpopulations Cubans had the 
highest proportion of deceased patients (63%) among all Latinos and also compared to 
NHW, followed by Puerto Ricans (58%). In contrast, Central/South Americans had the 
lowest proportion of deceased patients (44%). The observed differences within Latino 
subpopulations were statistically significant (p<0.001).
Clinical characteristics of Latino CRC cases in California
When comparing all Latino cases to NHW, no statistical differences were observed for the 
distribution of carcinoma in situ (CIS) versus malignant tumors (p = 0.084)(Table 2). 
However, differences were observed across Latino subpopulations, with Puerto Ricans 
having a slightly greater proportion of CIS (7%) than other subpopulations (4–5%; 
p<0.001).
Differences were also observed in tumor stage distribution, with Latinos showing a slightly 
higher proportion of stage IV tumors than NHW (20% in Latinos, versus 18% in NHW)
(p<0.001). Moreover, differences were observed across Latino subpopulations with Latinos 
of Mexican origin having the highest proportions of Stage IV tumors (23%) and Latinos 
from Cuba having the lowest (16%)(p<0.001)(Table 2).
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Latinos had a statistically significant higher proportion of rectal cases than NHW (33% 
versus 28%, p<0.001). Within Latino subpopulations, Mexicans (35%) had the highest 
proportion of rectal cancer, followed by Latinos of Other/NOS origin (32%) and South/
Central American Latinos (31%), whereas Cuban Latinos had much lower proportion of 
rectal cancer (23%)(p<0.001). Latinos also showed slightly higher proportion of larger 
tumors (>50 mm) than NHW (35% versus 31%, p<0.001). Among Latino subpopulations 
Latinos from Mexico had a significantly higher proportion of tumors larger than 50 mm 
(39%), followed by South/Central American Latinos (36%), whereas Latinos from Puerto 
Rico had the lowest proportion (30%)(p<0.001) (Table 2).
CRC incidence among Latinos in California
The age-adjusted incidence rate (AAIR) for all Latinos of in situ and invasive cancers 
combined was 47.2/100,000 in men and 31.6/100,000 in women. These rates were 20% and 
26% lower than the corresponding rates for NHW for the same period, which were 
58.7/100,000 and 43.6/100,000 for men and women, respectively. When we calculated 
AAIRs specifically for each Latino subpopulation, we observed considerable heterogeneity 
in CRC incidence rates among Latino subpopulations (Supplementary Table 1). AAIRs of 
most Latino subpopulations were lower than the AAIR for all Latino combined. For 
example, the incidence rate among Latino men and women of Mexican origin was only 
~one-third of the rates among all Latinos combined, respectively. In contrast, the incidence 
rate among Latino men and women of Cuban origin was only 8% and 15% lower than the 
one for all Latinos combined for men and women, respectively.
Given that there might be differences in how the numerator (cancer cases counts from CCR) 
and denominator (population counts from census) identified the different Latino 
subpopulations, this can lead to biased AAIR estimates. To address this, we estimated 
adjusted proportional incidence ratios (PIRs), which allowed us to determine if the observed 
number of CRC cases reported for each Latino subpopulation were comparable to the 
number of cases we expect to see given the proportion of CRC cases among all Latinos in 
California with respect to all cancer cases, and the total counts of cancer cases who belong 
to each Latino subpopulation. Given the observed statistically significant differences in age, 
sex, SES and nativity status distribution by Latino subpopulations, we estimated PIRs 
adjusting for these four variables to determine if any disparities would be observed when 
accounting for these important predictors of cancer incidence (Table 3). Among men, we 
found an excess of CRC cases from Cuba (PIR = 127; 95% CI = 114–141) and a non-
statistically significant reduced number of cases from Mexico (PIR = 97; 95% CI = 95–100). 
Among females, we also observed an excess of CRC cases from Cuba (PIR = 183; 95% CI = 
124–156), Puerto Rico (PIR = 113; 95% CI = 104–142), and for Latinos of other or 
unknown origin (PIR = 104; 95% CI = 102–106); and reduced number of cases from 
Mexico (PIR = 89; 95% CI = 87–92)(Table 3).
DISCUSSION
In this study we report that when considering subpopulations of Latinos defined by country 
of origin some important disparities emerge regarding the pattern of incidence. Specifically, 
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we observed that compared to NHW and other Latino subpopulations, Latinos from Mexico 
have a greater proportion of males compared to females, diagnosis at a younger age, stage 
IV cases, and rectal cancer cases. In contrast, compared to NHW and other Latino 
subpopulations, Latinos from South/Central America had higher proportion of females 
compared to males, and Latinos from Cuba had lower proportion of stage IV cases and 
lower proportion of rectal cases. Overall, among the considered Latino subpopulations, 
Mexican Latinos had the lowest observed incidence rates whereas Cuban-Latinos had the 
highest. When adjusting for SES and nativity fewer CRC cases were observed than expected 
among Mexican Latinos, whereas there was an excess of CRC cases among Cuban and 
Puerto Rican Latinos.
In agreement with our findings, a previous study based on SEER and Center for Disease 
Control National Program of Cancer Registries data reported PIRs that showed that 
compared to NHW, Mexican-Latinos and Latinos of South or Central American origin had 
slightly lower proportion of CRC, whereas Puerto Rican-Latinos had slightly higher 
proportion of CRC and Cuban Latinos had comparable proportion of CRC as NHW [12]. 
However, PIRs in that study were only adjusted for age, and not SES and nativity as we did 
in this study. A follow-up study used an indirect method that used US Census county 
demographic data to allocate Latinos at the aggregate level to subpopulations defined by 
country of origin, using these subpopulation-specific case counts to estimate AAIRs [6]. 
That study reported that whereas all Latinos combined had a colon cancer incidence lower 
than the incidence for NHW, Latinos of Cuban origin had higher colon cancer incidence 
than NHW, and those of Puerto Rican origin had an incidence that was still slightly lower 
than NHW, yet higher than those of Mexican origin or all Latinos combined [6]. Similar 
differences were observed for rectal cancer, although none of the incidence rates were 
higher than those for NHW. In another study, using individual level data, comparable 
observations were made for Latinos living in Florida, with Latinos of Mexican origin 
showing lower incidence rates than NHW in Florida whilst Puerto Ricans and Cubans living 
in Florida had higher CRC incidence rates than Florida NHW, with the difference being 
more pronounced for Cuban women [11]. In our study we did not observe that any 
subpopulation had incidence rates higher than NHW; however, similar to these previous 
reports, we observed that Cubans and Puerto Ricans had many more cases than expected, 
whereas Mexicans had fewer, and that the excess of cases for Cubans was greater for 
women than men.
Given that in the CCR more than 60% of Latinos cases were of unknown country of origin 
information, the subpopulation AAIRs underestimate the true incidence rate for each group. 
Moreover, our analyses show that most Latinos of unknown country or origin are US born 
(77%), and we do see differences in the proportion of US born versus foreign born Latinos 
across subpopulations. Hence, the missing birthplace data might be greater for some Latino 
subpopulations such as Latinos from Mexico or Puerto Rico than Latinos from Cuba and 
Central/South America. This may explain, at least partially, the lower AAIRs for Latinos 
from Mexico and Puerto Rico when compared to the AAIRs of all Latinos combined. 
Therefore, these AAIRs estimates illustrate the challenges presented by the missing 
birthplace data for Latinos, and should be interpreted with caution.
Stern et al. Page 7













Due to these concerns with AAIRs, and in light of the missing birthplace data, we think that 
the comparisons across subgroups using PIRs currently offer more accurate insights into 
possible CRC disparities within Latinos in California. When estimating PIRs, we take the 
proportion of CRC cases for all Latinos, and apply this proportion to the total counts for all 
cancers for each Latino subpopulation, taking into account age, sex, SES and nativity strata, 
and we take this to be our expected number of CRC cases for that subpopulation. Any 
statistically significant deviations from this number would indicate that there are more or 
fewer CRC cases in that subpopulation and this would be suggestive of disparities within 
Latinos in California. Even if under-reporting of birthplace were indeed differential by 
country of origin, we speculate this to be the case for any cancer, not just colorectal cancer. 
Therefore, the fact that we see differences in PIRs among subpopulations suggests that the 
disparities we see are unlikely to be due just by differences in nativity status and perhaps 
due to other risk determinants that are different across Latino subpopulations. Specifically, 
our conclusion based on PIRs showed a lower number of CRC cases from Mexican-Latinos 
than expected, and higher number of CRC cases from Puerto Rican Latinos and Cuban 
Latinas. These observed disparities deserve further investigation.
Among Latinos in California, higher SES is associated with higher incidence of CRC 
compared to lower SES [16]. Cuban and Puerto Rican Latinos in California have a 
significantly higher proportion of high SES cases than Mexican Latinos, which could be 
speculated to account for the observed higher proportion of CRC cases in these two 
subpopulations compared to other subpopulations. However, PIR estimates were adjusted 
for SES so this is unlikely to be the only explanation for the observed differences in 
proportions across subpopulations. Another difference between these two subpopulations of 
Latinos compared to Mexican Latinos is the fact that Latinos from the Caribbean have on 
average a greater proportion of African ancestry and reduced proportion of Indigenous 
American ancestry [18, 19]. It could be speculated that these differences in genetic 
background may contribute to differences in genetic susceptibility to environmental risk 
factors. Further studies need to be done to understand the possible sources of the observed 
differences in cancer incidence.
We observed that Latinos overall had a slightly greater proportion of advanced stage, with 
Mexican-Latinos having the greatest proportion. Latinos in general are reported to have 
lower rates for CRC screening (47%) compared to NHW (59%), and Latinos who live in 
mostly Latino neighborhoods have been reported to be more likely to be diagnosed with 
more advanced disease [2, 4–6]. Also, CRC screening has been reported to vary among US 
Latinos by English proficiency and by country of origin, with Mexican-Latinos being 
reported to have a lower rate of any type of CRC screening compared to Cuban- or Puerto 
Rican-Latinos [6, 20–23]. These findings are in agreement with the observed stage 
distributions in our study.
Our observation of a greater proportion of Latinos being diagnosed at younger age, is 
consistent with previous reports [24]. Among Latino subgroups in California we observed 
differences in the age population structure, with Cubans having a greater older population 
and Mexicans having the largest younger population. These differences in age population 
structure, along with increasing CRC rate due to recent westernization in some of these 
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subpopulations may partially explain the younger age at diagnosis. Moreover, this may be 
partially explained by possible genetic susceptibility factors that may predispose this 
population, and or higher exposure to CRC risk factors and/or loss of protective factors, and 
likely, a combination of genetic and environmental factors. Future studies on birth cohort 
effect and genetic susceptibility variants among Latinos will help elucidate these 
observations.
Strengths of our study include the use of population-based data from a SEER registry, which 
includes a wide range of SES, age at diagnosis, and countries of origin for Latinos living in 
California, which is the state with the largest number of Latinos in the US. A further 
strength is the use of a validated algorithm to identify most Latinos diagnosed with CRC in 
California [14]. The main weakness of our study is the missing country of origin information 
for more than 60% of cases. These missing data prevent us from estimating accurately the 
incidence rates of CRC among Latino subpopulations and raise the concern that differential 
underreporting may contribute to the observed disparities in rates. However, as explained 
above, our approach to estimate PIRs mitigates this concern and suggests that there are 
differences in the observed number of CRC cases across Latino subpopulation when 
compared to those expected based on the distribution of all cancer cases in California. 
Whether these differences are due to intrinsic characteristics of each Latino subpopulations, 
such as genetic ancestry, or due to lifestyle characteristics and environmental exposures, 
and/or a complex interplay between all of these factors, deserves further investigation. 
Moreover, we cannot discard the possibility that PIRs may not be accurate if, for example, 
one or more of the subpopulations had a significantly larger number of cases of a specific 
cancer, which would impact the proportion of CRC with respect to all cancers, an thus affect 
the accuracy of our PIR estimates. Therefore, to more accurately estimate cancer incidence 
rates and understand tumor characteristic disparities across Latino subpopulations with even 
higher numbers it will be of high importance to improve the collection of country of origin 
data on Latino patients, in order to reduce the impact and possible biases introduced by 
missing data. It is feasible that US born Latinos because of higher acculturation might be 
less likely to report country of origin of their family, and physicians perhaps less likely to 
inquire about this, contributing to missing data in the reports made to the cancer registry. 
Another limitation is the fact that even though we used an established algorithm to impute 
missing nativity (foreign born vs. US-born), we cannot discard the possibility of 
misclassification. Finally, another weakness of our study is that we did not have adequate 
numbers to subdivide patients from Central and South American origin and thus had to 
study them together, which is not ideal as there are disparities in CRC incidence across 
Central and South American countries.
In summary, our study reports disparities in cancer incidence patterns and several 
demographic and clinical characteristics across Latino subpopulations defined by country of 
origin in California. These findings highlight the importance of taking into account the 
heterogeneity within Latino populations and the importance of improving the collection of 
data on country of origin in order to understand further the underlying causes of the 
observed differences. Given that currently cancer is the number one cause of death among 
Latinos, understanding the patterns of incidence and presentation in this population with 
more precision is of high public health relevance.
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Table 3
Adjusted proportional incidence ratios (PIRs) for Hispanic subcategories
Adjusted for age, SES and nativity
Cases Expected Cases 100%PIR 95% Cl
Males by country of origin
Mexican 5,474 5,636 97 95–99.6
Cuban 304 239 127 114–141
Puerto Rican 158 150 105 91–121
South/Central American 1,155 1,176 98 93–104
Other/NOS Latinos 12,483 12,372 101 99–103
Females by country of origin
Mexican 4,204 4,707 89 87–92
Cuban 254 183 139 124–156
Puerto Rican 137 113 121 104–142
South/Central American 1,481 1,446 102 98–108
Other/NOS Latinos 10,483 10,110 104 102–106
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